Efficacy, safety and ease of use of a thin Algostéril in the local care of wounds

Efficacy, safety and ease of use of a thin Algostéril in the local care of wounds: a monocentric prospective study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14026011

Enrollment

Registered

2016-01-06

Start date

2015-12-04

Completion date

Unknown

Last updated

2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds Injury, Occupational Diseases, Poisoning

Interventions

Each patient is treated with a Algostéril dressing until wound healing in about one month.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient : 1. aged 18 years or older 2. with a wound that needs to be treated by a thin Algostéril 3. who can be followed until the wound healing 4. who signed informed consent form

Exclusion criteria

Exclusion criteria: Participant or participating in another clinical trial within 30 days prior to inclusion

Design outcomes

Primary

Measure	Time frame
Number of days of treatment to obtain the wound healing, checked by the methylene blue test	—

Secondary

Measure	Time frame
1. Ease of use 2. Assessment of safety throughout the trial	—

Countries

France

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026